Independent · non-commercial · educational

About & contact

Dozemir is a free educational reference for dose equivalence, «Доступні ліки» reimbursement status, and pharmacokinetics.

Viktor Didyk

Biomedical engineer

I'm a biomedical engineer. I started Dozemir on 29 May 2026, because the equivalent-dose tables I kept finding online almost never said where the number came from.

Principles

Correctness before coverage

A drug or class ships only when a published method exists for it. No number appears without a citation.

Honest refusals

Where no validated method exists, the tool says so — a refusal is a first-class answer, not an error.

Non-prescriptive by design

The tool estimates and shows its source. It does not prescribe.

Method review

Each computational method is checked against its cited sources. Independent clinical-pharmacology review is planned. pending

Found a wrong number?

If a figure, ratio, or citation looks wrong, write. Say which screen, and which source you're checking against.

Report a correction

Data & provenance

Equivalence and pharmacokinetic methods rest on peer-reviewed literature. Each is cited on its own screen with a verbatim quote and an evidence rating.

Reimbursement status comes from the NSZU «Доступні ліки» full list (nszu.gov.ua), with a verified-as-of date on every marker.

Open the register (opens in a new tab)

What this is not

No ads, no sponsored placements, no prices. No ties to any manufacturer or pharmacy.

Educational PK model: not clinical guidance. Confirm any dose change with a prescriber or pharmacist.